Alkermes (ALKS) - Stock price history

Stock price history of Alkermes from 1991 to 2025

Annual Stock Price Performance

Year	Performance
2025	1.46%
2024	0.49%
2023	7.23%
2022	8.20%
2021	17.83%
2020	0.96%
2019	-29.92%
2018	-46.56%
2017	-2.44%
2016	-25.72%
2015	36.30%
2014	45.53%
2013	110.89%
2012	6.81%
2011	38.33%
2010	26.47%
2009	-12.14%
2008	-29.47%
2007	19.10%
2006	-34.84%
2005	36.47%
2004	0.86%
2003	102.70%
2002	-75.65%
2001	-4.58%
2000	23.04%
1999	110.16%
1998	11.64%
1997	-11.17%
1996	210.00%
1995	284.85%
1994	-71.19%
1993	-22.22%
1992	-52.78%
1991	63.64%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Acorda Therapeutics ACOR	0,56 €	0.00%	🇺🇸 USA
Bristol-Myers Squibb BMY	43,60 €	-0.02%	🇺🇸 USA
Johnson & Johnson JNJ	178,82 €	1.68%	🇺🇸 USA
Pfizer PFE	21,97 €	0.08%	🇺🇸 USA
AstraZeneca AZN	76,88 €	-1.33%	🇬🇧 UK
Teva Pharmaceutical Industries TEVA	25,70 €	1.28%	🇮🇱 Israel
Zogenix ZGNX	22,72 €	0.00%	🇺🇸 USA
Sanofi SNY	41,60 €	1.24%	🇫🇷 France
Novartis NVS	112,70 €	0.89%	🇨🇭 Switzerland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Alkermes (ALKS)